Peptron Inc
KOSDAQ:087010
Intrinsic Value
Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. [ Read More ]
The intrinsic value of one Peptron Inc stock under the Base Case scenario is 585.57 KRW. Compared to the current market price of 30 700 KRW, Peptron Inc is Overvalued by 98%.
Valuation Backtest
Peptron Inc
Run backtest to discover the historical profit from buying and selling Peptron Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Peptron Inc
Current Assets | 11.2B |
Cash & Short-Term Investments | 7.5B |
Receivables | 733m |
Other Current Assets | 3B |
Non-Current Assets | 43.6B |
Long-Term Investments | 2.6B |
PP&E | 39B |
Intangibles | 698.7m |
Other Non-Current Assets | 1.3B |
Current Liabilities | 10.7B |
Accounts Payable | 240.7m |
Accrued Liabilities | 290.7m |
Short-Term Debt | 3B |
Other Current Liabilities | 7.2B |
Non-Current Liabilities | 4.6B |
Long-Term Debt | 33m |
Other Non-Current Liabilities | 4.5B |
Earnings Waterfall
Peptron Inc
Revenue
|
3.3B
KRW
|
Cost of Revenue
|
-2.2B
KRW
|
Gross Profit
|
1.1B
KRW
|
Operating Expenses
|
-17B
KRW
|
Operating Income
|
-15.9B
KRW
|
Other Expenses
|
-38m
KRW
|
Net Income
|
-15.9B
KRW
|
Free Cash Flow Analysis
Peptron Inc
Profitability Score
Profitability Due Diligence
Peptron Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Peptron Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Peptron Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Peptron Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Peptron Inc
According to Wall Street analysts, the average 1-year price target for Peptron Inc is 35 000 KRW .
Shareholder Return
Price
Peptron Inc
Average Annual Return | -22.05% |
Standard Deviation of Annual Returns | 12.68% |
Max Drawdown | -71% |
Market Capitalization | 631B KRW |
Shares Outstanding | 20 552 939 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Peptron, Inc. engages in the development of peptide-based medicines and novel drugs. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2015-07-22. The firm mainly produces peptides as drug materials mainly for prostate cancer, hyperpituitarism, diabetes and neurodegenerative disorders. The firm also provides peptide synthesis services. The firm manufactures raw material medicines and some functional cosmetics. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Peptron Inc stock under the Base Case scenario is 585.57 KRW.
Compared to the current market price of 30 700 KRW, Peptron Inc is Overvalued by 98%.